FY2026 Medical Fee Revision to Take Effect June 1st; Notifications to MHLW Start May 7th – Tsugino Jidai

Early Announcement of the FY2026 Medical Fee Revision and Its Implications

Information regarding the FY2026 medical fee revision has been disclosed earlier than usual, with an effective date of June 1st and notification commencement on May 7th. This is believed to be intended to provide medical institutions with ample time to review and prepare for the revision details. Particularly, changes in facility standards and the introduction of new additional or reduced payment items directly impact the revenue structure of individual medical institutions, making early disclosure of information crucial for formulating management strategies.

Implications from an M&A and Business Succession Perspective

Medical fee revisions are one of the most critical factors determining the sustainability of medical institutions. It is essential to formulate medium- to long-term management strategies, and consequently, business succession strategies, with the revision cycle in mind. For example, there may be an increase in medical corporations considering mergers or group formations to pursue economies of scale, maintain facility standards, and distribute the burden of high-cost capital investments. Furthermore, utilizing tax schemes such as transitioning to specific medical corporations or social medical corporations will likely be increasingly emphasized as options for business succession.

Concrete insights for healthcare executives and successors

This early announcement should be viewed not merely as a notification of a system change, but as a signal for management to proactively prepare for change. It presents an excellent opportunity to meticulously analyze how one's own institution's revenue structure will be affected by the revision and to commence revisions of management plans or business succession plans accordingly. In particular, medical institutions struggling with a lack of successors can leverage this revision cycle to consider business succession through M&A or group formation at an early stage, potentially finding more favorable succession terms or options that contribute to the maintenance of regional healthcare.